Attention Health and MedTech companies: If you’re looking to accelerate your growth, don’t miss this event hosted by Medilink Midlands and Health Tech Enterprise.
With over 20 years of experience supporting MedTech and Life Sciences companies, we invite you to hear directly from industry leaders, regional support organisations, and businesses that have already benefited from our assistance.
This event is also your chance to influence the future of support in the East of England and contribute to shaping the vision of a MedTech Cluster in the region.
“SEHTA is delighted to partner with Medilink Midlands to talk to the audience about how SEHTA can support SMEs in the East of England from the MedTech and Life Sciences sector” – Neil Roberts, Managing Director, SEHTA
Don’t miss this opportunity to connect, learn and have your voice heard!
Programme:
10:15am – Registrations, Refreshments & Networking
11:00am – Host Welcome & Introduction, James Fry, Partner, Head of Life Sciences, Mills & Reeve
11:05am – Strategic Overview & Welcome, Melanie Davidson, Chief Executive Officer, Medilink Midlands & Dr Anne Blackwood, CEO, Health Tech Enterprise
11:10am – The role of Health Innovation East in supporting companies to help generate improved heath and wealth in the East of England, Philip Shelton, Head of Industry Partnerships and Net Zero Lead, Health Innovation East
11:30am – Turning ideas into successful medical devices, Danny Godfrey, Co-Founder & Director, eg technology
11:50pm – Leveraging Support for Success: My Journey of Innovation in the NHS, Dr Shaobin Wu, Co-Founder, C-Prio Ltd
12:05pm – Refreshments & Networking
12:20pm – Health Tech Enterprise Support, Max Bardwell, Head of Business Development, Health Tech Enterprise
12:25pm – Medilink Midlands Support, Raghul Senthilnathan, Innovation Adviser, Medilink Midlands
12:30pm – SEHTA Support for SMEs, Neil Roberts, Managing Director, SEHTA
12:35pm – Anglia Ruskin University Support, Dr Beverley Vaughan, Arise Innovation Hubs Director, Anglia Ruskin University
12:40pm – Group Breakouts: What support you would like to see in the East of England and what a MedTech Cluster would look like
13:15pm – Closing Remarks and Next Steps, Melanie Davidson, Chief Executive Officer, Medilink Midlands
13:25pm – Lunch & Networking
CLICK HERE TO BOOK YOUR PLACE*
Please ensure that you secure your free place, as spaces are limited and available on a first come, first served basis, priority will be given to East of England organisations.
*Spaces are now full, to be added to the waiting list email: events@medilinkmidlands.com
Hosted by:
Speaker Profiles:
James Fry, Partner, Head of Life Sciences, Mills & Reeve
James is a leading life sciences lawyer and heads the firm’s multi-disciplinary life sciences practice. He specialises in advising businesses and organisations in the sector on intellectual property matters and complex commercial contracting. In particular, James has longstanding and deep knowledge of research and technology collaborations, intellectual property licensing and the distribution and promotion of medical and medicinal products. He also regularly advises on regulatory issues relevant to the sector, such as product classification, clinical trials and advertising. His clients include GSK, Illumina, F-star, The Binding Site, NRG Therapeutics, Mission Therapeutics and Neurocrine Biosciences. James has been ranked in the Intellectual Property sections of Chambers and Partners for many years. The Directories describe James as “an excellent lawyer” (Legal 500) and “an outstanding IP practitioner and life sciences specialist” (Chambers).
Melanie Davidson, Chief Executive Officer, Medilink Midlands
Melanie brings a background of industrial research and business development from West Pharmaceutical Service’s Drug Delivery Division. She also broadens our bioscience reach having studied Animal Science at The University of Nottingham. Before joining Medilink, Melanie gained valuable experience in economic development and international investment at the East Midlands Development Agency (emda).
Dr Anne Blackwood, CEO, Health Tech Enterprise
Anne is Chief Executive of Health Tech Enterprise (HTE), a leading NHS innovation and technology consultancy based in Cambridge. Anne has been actively involved in intellectual property management and commercialisation of life science technologies for over 20 years. She is also Chair of the Medtech Accelerator, a joint venture with public sector partners that awards proof of concept funding to develop medical technologies that meet a clinical need in the NHS. She was formerly Chair and co-founder of Medovate, a venture backed innovation development company dedicated to the commercialisation of medical technologies created within the NHS. Anne is passionate about improving the quality and efficiency of healthcare services through technology and innovation.
Philip Shelton PhD, Head of Industry Partnerships and Net Zero Lead, Health Innovation East
Philip joined Health Innovation East in 2020 from Philips and has over 20 years’ experience in life sciences, NHS research and implementation and digital health. He specialises in AI and imaging and innovation focusing on helping the NHS reach their Net Zero targets.
As Head of Industry Partnerships and Net Zero Lead within our commercial team he is responsible for consulting and building a range of strategic partnerships with national and internation companies. These include Bayer, Fujitsu, Abbott and AstraZeneca. He is further supporting the two Imaging Networks in the East of England. Philip also takes a lead role in the national Net Zero and sustainability portfolio and recently was commissioned to conduct two evaluation studies on Apollo Phase Change Solutions panels and the Net Zero benefits of the Abbott Indexor pre-analytics system.
Danny Godfrey, Co-Founder & Director, eg technology
Danny co-founded eg technology ltd in 2002, with fellow director Andrew Ede. Based in Cambridge (UK), eg technology is a product design, engineering and development consultancy, specialising in the MedTech sector, which has now grown to employ over 40 engineering and commercial staff. With a BA and MEng in Engineering from Cambridge University and more than 20 years’ experience in product design and engineering, Danny’s role is to provide corporate leadership, develop new business opportunities and oversee the technical and strategic direction of projects. He has in depth knowledge of the entire project life cycle, from the initial proposal writing, technical & creative input, design implementation, review processes and the early identification of development risks. Motivating staff and nurturing client relationships are important aspects of Danny’s day-to-day work – valuing and developing our team of bright, can-do people and ensuring clients are satisfied with what eg does have been the foundations of success for the company.
Dr Shaobin Wu, Co-Founder, C-Prio Ltd
Dr. Shaobin Wu is a Consultant Histopathologist and the newly appointed Trust Clinical Lead for Genomics at East Suffolk and North Essex Foundation Trust. With a deep passion for healthcare innovation, Dr. Wu has played a key role in advancing digital transformation within the NHS. As a Topol Digital Fellow and NHS Clinical Entrepreneur, she has developed valuable skills in agile project management, person-centred design, and the integration of digital technologies in healthcare.
In addition to her clinical roles, Dr. Wu is the Co-founder of C-Prio Ltd, where she takes the leadership role to leverage AI and automation to address critical challenges in NHS histopathology service, particularly in cancer diagnostics. Her entrepreneurial journey is distinguished by the strategic support and funding she has received from the Arise ABOVE program, which have been instrumental in progressing her visionary ideas towards impactful solutions. Through her leadership and commitment, Dr. Wu continues to push the boundaries of what’s possible in healthcare, making meaningful contributions to both clinical practice and the broader entrepreneurial landscape.
Max Bardwell, Head of Business Development, Health Tech Enterprise
An experienced professional in technology development and innovation, Max Bardwell joined HTE in 2022 as Head of Business Development. His role is varied and includes developing new commercial partnerships, opening up new market opportunities and driving sales growth. Max has 20 years of experience in the development of scientific instrumentation and medical technologies and has worked for number of higher education institutions and spin out companies in research, technology transfer and commercialisation of technology innovations. He has experience in the protection and exploitation of intellectual property, project management and effective collaborative strategic partnership between industry and academia. Max has a BSc in Chemistry from Nottingham Trent University, an MBA from the Open University and a PhD in Atmospheric Chemistry from Nottingham Trent University.
Raghul Senthilnathan, Innovation Adviser, Medilink Midlands
Raghul is a dynamic Innovation Adviser with a master’s degree in Biotech and Pharma Management from UCL, he has a very strong background in life sciences and healthcare innovation. He has successfully founded two innovative start ups and has personal expertise in digital technologies. Raghul is skilled in leading accelerator programmes and supporting early stage companies to navigate challenges and realise their potential in contributing to the economy. He also has expertise in coaching, mentoring and business diagnostics to help innovators avoid pitfalls and succeed.
Neil Roberts, Managing Director, SEHTA
Neil has been the Managing Director since April 2021, having previously been COO since July 2018. In July 2022, Neil was appointed non-executive Chairman to the Board of Exhalation Technology Ltd, which has attracted more than £11m in investor funding. In addition he is a business Mentor at Imperial College, London, as part of the Imperial Venture Mentoring Service.
Based on more than 30 years as a Senior Executive in the medical technology market, he has a track record of success in driving business development and growth, via sales and marketing, domestic and international distributor management, market access, major accounts, new business integration, and change management. This has been gained in the UK and in export both within an SME and market leading corporate environment. His approach is based on pragmatism, enabled by detailed market understanding, with the highest importance placed on the execution of consequent action plans as the key to success. He has managed product though NICE Technology Appraisal (TA), and other market access processes. Served as Industry Representative on the RCOphth Working Party into the safety of laser eye surgery in the UK, and as Chair of the Ophthalmic Special Interest Group at the ABHI. A degree in Medical Biochemistry from London University has been enhanced by business management education at Ashridge and the completion of leadership studies at Harvard.
Dr Beverley Vaughan, Arise Innovation Hubs Director, Anglia Ruskin University
Beverley joined the Arise Innovation Hubs as Director in June 2021, with over 20 years’ experience in the healthcare and life sciences sector. Beverley trained as a clinical scientist in Haematology and working at Cambridge and London University Hospitals. Working in the innovation sector for the last 10 years with roles in Stevenage Bioscience Catalyst (SBC), Cell and Gene Therapy Catapult (CGT) and the University of Oxford. Whilst at SBC Beverley supported the development of translational research facilities and raised funding from multiple pharma and biotech companies for the Open Innovation Challenge in Neurodegeneration. At CGT Beverley managed a wide portfolio of project from novel drug discovery spin outs to NHS led delivery of cell therapy products. Most recently she was responsible for the delivery of a drug discovery consortium-UKSPINE- pivoting traditional pathways to meet the demands of healthy aging with partners, Universities of Oxford, Dundee and Birmingham, Medicines Discovery Catapult, The Francis Crick Institute and Sanger Centre Cambridge. Since joining Arise as Director Beverley has been working on building the life science strategy for their newest hub located on the Harlow Innovation Park, leading on strategy, fund raising and partnering activities to build a cluster of expertise within this synapse of the London-Cambridge corridor. She is also a member of the NC3Rs CRACKIT advisory panel.